InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (39 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
39
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Paulson Richard A., Chairman & CEO. Insider active across 2 companies, notably Karyopharm Therapeutics Inc.. Aggregated, 52 filings have been logged. Breakdown: 0 buy · 39 sells. Total volume traded: €490k. Activity tracked since 3 May 2021. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Paulson Richard A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
4,920 shares0Common StockSEC:0001193125-26-226613:0
12,361 shares@ US$9.409520.2% of flowCommon StockSEC:0001804460-26-000003:0
81,060 shares0Common StockSEC:0001193125-26-042799:0
114,285 shares0Common StockSEC:0001193125-25-241471:0
2,800 shares0Common StockSEC:0001193125-25-205052:0
155 sharesCommon StockSEC:0000950170-25-081108:0
236 shares@ US$7.120.4% of flowCommon StockSEC:0000950170-25-065884:0
245 shares@ US$3.740.2% of flowCommon StockSEC:0000950170-25-051658:0
11,694 shares@ US$6.2917.9% of flowCommon StockSEC:0000950170-25-034736:0
20,000 shares0Common StockSEC:0000950170-25-032297:0
4,099 shares@ US$0.650.7% of flowCommon StockSEC:0000950170-25-014491:0
4,055 shares@ US$0.7830.8% of flowCommon StockSEC:0000950170-25-002819:0
3,620 shares@ US$0.810.7% of flowCommon StockSEC:0000950170-24-133689:0
24,900 shares0Common StockSEC:0001562180-24-007607:0
3,675 shares@ US$0.91060.8% of flowCommon StockSEC:0000950170-24-122274:0
3,607 shares@ US$0.87930.7% of flowCommon StockSEC:0000950170-24-113263:0
3,667 shares@ US$0.72180.6% of flowCommon StockSEC:0000950170-24-104033:0
3,608 shares@ US$0.92990.8% of flowCommon StockSEC:0000950170-24-094087:0
3,616 shares@ US$0.8510.7% of flowCommon StockSEC:0000950170-24-082417:0
3,592 shares@ US$0.990.8% of flowCommon StockSEC:0000950170-24-069856:0
3,576 shares@ US$1.131.0% of flowCommon StockSEC:0000950170-24-054686:0
3,563 shares@ US$1.291.1% of flowCommon StockSEC:0000950170-24-042350:0
3,573 shares@ US$1.301.1% of flowCommon StockSEC:0000950170-24-027153:0
80,470 shares@ US$1.1722.2% of flowCommonSEC:0000950170-24-025188:0
442,800 shares0Common StockSEC:0000950170-24-023281:0
25 of 52 declarations
About Paulson Richard A.
Paulson Richard A. is Président-Directeur Général. He has 52 filings in total, and in the 52 sampled filings between 2021-05-04 and 2026-05-15, the transactions are sales for a total of EUR 490321, with no purchases indicated. The filings concern Karyopharm Therapeutics Inc. and bluebird bio, Inc.
